Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Depreciation and Depletion: 2018-2024

Historic Depreciation and Depletion for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to $50,000.

  • Eton Pharmaceuticals' Depreciation and Depletion fell 33.33% to $8,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $62,000, marking a year-over-year increase of 24.00%. This contributed to the annual value of $50,000 for FY2024, which is 13.64% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Depreciation and Depletion stood at $50,000 for FY2024, which was up 13.64% from $44,000 recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Depreciation and Depletion ranged from a high of $155,000 in FY2021 and a low of $44,000 during FY2023.
  • Its 3-year average for Depreciation and Depletion is $53,333, with a median of $50,000 in 2024.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Depreciation and Depletion tumbled by 57.42% in 2022, and later grew by 13.64% in 2024.
  • Over the past 4 years, Eton Pharmaceuticals' Depreciation and Depletion (Yearly) stood at $155,000 in 2021, then plummeted by 57.42% to $66,000 in 2022, then crashed by 33.33% to $44,000 in 2023, then rose by 13.64% to $50,000 in 2024.